PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10041LMP | PAZOPANIB pazopanib 400 mg tablet, 60 (PI, CMI) |
1 | 60 | 2 | $1736.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10042MMP | PAZOPANIB pazopanib 200 mg tablet, 90 (PI, CMI) |
1 | 90 | 2 | $1318.99 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10043NMP | PAZOPANIB pazopanib 400 mg tablet, 60 (PI, CMI) |
1 | 60 | 5 | $1736.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10047TMP | PAZOPANIB pazopanib 200 mg tablet, 90 (PI, CMI) |
1 | 90 | 5 | $1318.99 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10052CMP | PAZOPANIB pazopanib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $901.21 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10054EMP | PAZOPANIB pazopanib 200 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $457.99 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11252FMP | PAZOPANIB pazopanib 200 mg tablet, 90 (PI, CMI) |
1 | 90 | 5 | $1318.99 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 11261QMP | PAZOPANIB pazopanib 400 mg tablet, 60 (PI, CMI) |
1 | 60 | 5 | $1736.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 2029TMP | PAZOPANIB pazopanib 200 mg tablet, 90 (PI, CMI) |
1 | 90 | 2 | $1318.99 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 2030WMP | PAZOPANIB pazopanib 400 mg tablet, 60 (PI, CMI) |
1 | 60 | 2 | $1736.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 2201WMP | PAZOPANIB pazopanib 400 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $901.21 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
PAZOPANIB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > PROTEIN KINASE INHIBITORS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 2232LMP | PAZOPANIB pazopanib 200 mg tablet, 30 (PI, CMI) |
1 | 30 | 5 | $457.99 | $31.60 | $31.60 |
| Available brands | |||||||
| Pazopanib ADVZa | |||||||
| Votrienta |
- Legend
- aBrand equivalent a
- MPMedical Practitioner




